Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation

Part of paid clinical trials in Dublin, Ohio.

Sponsor
Medinutra LLC
Study ID
NCT07063056
Status
Recruiting
Apply to this trial

Conditions

  • Triglycerides

Eligibility Criteria

Sex
ALL
Age
21 Years - 59 Years
Healthy Volunteers
Accepted

Interventions

  • Curcumin (Longvida™) — DIETARY_SUPPLEMENT
    1 capsule per day at a usual curcumin dose for this particular product (80 mg curcumin)
  • Half Dose Curcumin (Longvida™) — DIETARY_SUPPLEMENT
    1 capsule per day at half the usual curcumin dose for this particular product (40 mg curcumin as the half dose)
  • Astaxanthin — DIETARY_SUPPLEMENT
    1 capsule per day at a usual astaxanthin dose (12 mg)
  • Placebo Control — OTHER
    Subject will get 1 capsule per day of a small amount of cellulose

Study Details

Two dietary supplements are each being compared to a placebo for the ability to help maintain triglycerides in the normal range. The subjects will be adult men and women with moderately high TG values. Serum triglycerides will be measured before and after 6 weeks of taking 1 capsule per day of either Longvida Curcumin, astaxanthin, or a placebo. A few side blood analysis will also be done. These measures are relevant to low level inflammation.

Key Dates

Start date
Jul 18, 2025
Status verified
Jul 2025
Primary completion
Nov 15, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
64 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Placebo Comparator: Control
    Subjects will be given 1 capsule per day of a small amount of cellulose
  • Experimental: Regular dose curcumin
    Subjects will be given 1 capsule per day of a typical amount of Longvida curcumin (80 mg curcumin)
  • Experimental: Low dose curcumin
    Subjects will be given 1 capsule per day of 40 mg curcumin which is half the typical amount of Longvida curcumin
  • Experimental: Astaxanthin
    Subjects will be given 1 capsule per day of a typical amount of astaxanthin (12 mg curcumin)

Primary Outcome Measure

Trilgycerides [ Time Frame: Pre and post 6 week intervention ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Medinutra LLCDublinOhio43016
Robert DiSilvestro, Ph.D.
[email protected]
614-348-9375

Find similar trials in Dublin, OH

By research site
Medinutra LLC· Dublin, OH

Related Studies